查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1442869

獸醫分子診斷市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Veterinary Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

獸醫分子診斷市場 - 報告範圍

TMR 關於全球獸醫分子診斷市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球獸醫分子診斷的收入2017-2031年期間的市場，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球獸醫分子診斷市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解獸醫分子診斷市場。

該報告深入研究了全球獸醫分子診斷市場的競爭格局。全球獸醫分子診斷市場的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球獸醫分子診斷市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 主要產品/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依產品類型

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依產品類型，2017-2031
    • 儀器與軟體
    • 試劑盒和試劑
    • 服務
  • 市場吸引力：按產品類型

第 7 章：全球市場分析與預測：依技術分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依技術分類，2017-2031
    • 常規PCR
    • 單重PCR
    • 多重PCR
    • 即時定量PCR
    • 其他
    • 7.4 市場吸引力：依技術分類

第 8 章：全球市場分析與預測：按疾病類型

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依疾病類型，2017-2031
    • 媒介傳播疾病
    • 呼吸道病原體
    • 腹瀉病原體
    • 其他
  • 市場吸引力：按疾病類型

第 9 章：全球市場分析與預測：按動物類型

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依動物類型，2017-2031
    • 伴侶動物
    • 畜牧動物
  • 市場吸引力：依動物類型

第 10 章：全球市場分析與預測：按最終用戶

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 醫院/診所
    • 參考實驗室
  • 市場吸引力：按最終用戶分類

第 11 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力：按地區

第 12 章：北美市場分析與預測

第 13 章：歐洲市場分析與預測

第 14 章：亞太市場分析與預測

第 15 章：拉丁美洲市場分析與預測

第 16 章：中東和非洲市場分析與預測

第17章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • IDEXX Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • Zoetis, Inc.
    • Neogen Corporation
    • bioMerieux SA
    • QIAGEN NV
    • Biomedica Medizinprodukte GmbH
    • Bioneer
    • Mars, Incorporated
    • Innovative Diagnostics
Product Code: TMRGL42437

Veterinary Molecular Diagnostics Market - Scope of Report

TMR's report on the global veterinary molecular diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global veterinary molecular diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global veterinary molecular diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the veterinary molecular diagnostics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global veterinary molecular diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global veterinary molecular diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global veterinary molecular diagnostics market.

The report delves into the competitive landscape of the global veterinary molecular diagnostics market. Key players operating in the global veterinary molecular diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global veterinary molecular diagnostics market profiled in this report.

Key Questions Answered in Global veterinary molecular diagnostics market Report:

  • What is the sales/revenue generated by wearable injectors across all regions during the forecast period?
  • What are the opportunities in the global veterinary molecular diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Veterinary Molecular Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global veterinary molecular diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global veterinary molecular diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global veterinary molecular diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Veterinary Molecular Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Product Type

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Instruments & Software
    • 6.3.2. Kits & Reagents
    • 6.3.3. Services
  • 6.4. Market Attractiveness, by Product Type

7. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Technology

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2017-2031
    • 7.3.1. Conventional PCR
    • 7.3.2. Singleplex PCR
    • 7.3.3. Multiplex PCR
    • 7.3.4. Real-time PCR
    • 7.3.5. Others
    • 7.3.6. 7.4 Market Attractiveness, by Technology

8. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, By Disease Type

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, By Disease Type, 2017-2031
    • 8.3.1. Vector-borne Diseases
    • 8.3.2. Respiratory Pathogens
    • 8.3.3. Diarrhea Pathogens
    • 8.3.4. Others
  • 8.4. Market Attractiveness, By Disease Type

9. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Animal Type

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Animal Type, 2017-2031
    • 9.3.1. Companion Animal
    • 9.3.2. Livestock Animal
  • 9.4. Market Attractiveness, by Animal Type

10. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by End-user

  • 10.1. Introduction and Definitions
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals/Clinics
    • 10.3.2. Reference Laboratories
  • 10.4. Market Attractiveness, by End-user

11. Global Veterinary Molecular Diagnostics Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region, 2017-2031
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness, by Region

12. North America Veterinary Molecular Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Instruments & Software
    • 12.2.2. Kits & Reagents
    • 12.2.3. Services
  • 12.3. Market Attractiveness, by Product Type
  • 12.4. Market Value Forecast, by Technology, 2017-2031
    • 12.4.1. Conventional PCR
    • 12.4.2. Singleplex PCR
    • 12.4.3. Multiplex PCR
    • 12.4.4. Real-time PCR
    • 12.4.5. Others
  • 12.5. Market Attractiveness, by Technology
  • 12.6. Market Value Forecast, By Disease Type, 2017-2031
    • 12.6.1. Vector-borne Diseases
    • 12.6.2. Respiratory Pathogens
    • 12.6.3. Diarrhea Pathogens
    • 12.6.4. Others
  • 12.7. Market Attractiveness, By Disease Type
  • 12.8. Market Value Forecast, by Animal Type, 2017-2031
    • 12.8.1. Companion Animal
    • 12.8.2. Livestock Animal
  • 12.9. Market Attractiveness, by Animal Type
  • 12.10. Market Value Forecast, by User End-user, 2017-2031
    • 12.10.1. Hospitals/Clinics
    • 12.10.2. Reference Laboratories
  • 12.11. Market Attractiveness, by End-user
  • 12.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.12.1. U.S.
    • 12.12.2. Canada
  • 12.13. Market Attractiveness Analysis
    • 12.13.1. By Product Type
    • 12.13.2. By Technology
    • 12.13.3. By Disease Type
    • 12.13.4. By Animal Type
    • 12.13.5. By End-user
    • 12.13.6. By Country

13. Europe Veterinary Molecular Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Instruments & Software
    • 13.2.2. Kits & Reagents
    • 13.2.3. Services
  • 13.3. Market Attractiveness, by Product Type
  • 13.4. Market Value Forecast, by Technology, 2017-2031
    • 13.4.1. Conventional PCR
    • 13.4.2. Singleplex PCR
    • 13.4.3. Multiplex PCR
    • 13.4.4. Real-time PCR
    • 13.4.5. Others
  • 13.5. Market Attractiveness, by Technology
  • 13.6. Market Value Forecast, By Disease Type, 2017-2031
    • 13.6.1. Vector-borne Diseases
    • 13.6.2. Respiratory Pathogens
    • 13.6.3. Diarrhea Pathogens
    • 13.6.4. Others
  • 13.7. Market Attractiveness, By Disease Type
  • 13.8. Market Value Forecast, by Animal Type, 2017-2031
    • 13.8.1. Companion Animal
    • 13.8.2. Livestock Animal
  • 13.9. Market Attractiveness, by Animal Type
  • 13.10. Market Value Forecast, by User End-user, 2017-2031
    • 13.10.1. Hospitals/Clinics
    • 13.10.2. Reference Laboratories
  • 13.11. Market Attractiveness, by End-user
  • 13.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.12.1. Germany
    • 13.12.2. U.K.
    • 13.12.3. France
    • 13.12.4. Italy
    • 13.12.5. Spain
    • 13.12.6. Rest of Europe
  • 13.13. Market Attractiveness Analysis
    • 13.13.1. By Product Type
    • 13.13.2. By Technology
    • 13.13.3. By Disease Type
    • 13.13.4. By Animal Type
    • 13.13.5. By End-user
    • 13.13.6. By Country/Sub-region

14. Asia Pacific Veterinary Molecular Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Instruments & Software
    • 14.2.2. Kits & Reagents
    • 14.2.3. Services
  • 14.3. Market Attractiveness, by Product Type
  • 14.4. Market Value Forecast, by Technology, 2017-2031
    • 14.4.1. Conventional PCR
    • 14.4.2. Singleplex PCR
    • 14.4.3. Multiplex PCR
    • 14.4.4. Real-time PCR
    • 14.4.5. Others
  • 14.5. Market Attractiveness, by Technology
  • 14.6. Market Value Forecast, By Disease Type, 2017-2031
    • 14.6.1. Vector-borne Diseases
    • 14.6.2. Respiratory Pathogens
    • 14.6.3. Diarrhea Pathogens
    • 14.6.4. Others
  • 14.7. Market Attractiveness, By Disease Type
  • 14.8. Market Value Forecast, by Animal Type, 2017-2031
    • 14.8.1. Companion Animal
    • 14.8.2. Livestock Animal
  • 14.9. Market Attractiveness, by Animal Type
  • 14.10. Market Value Forecast, by User End-user, 2017-2031
    • 14.10.1. Hospitals/Clinics
    • 14.10.2. Reference Laboratories
  • 14.11. Market Attractiveness, by End-user
  • 14.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.12.1. China
    • 14.12.2. Japan
    • 14.12.3. India
    • 14.12.4. Australia & New Zealand
    • 14.12.5. Rest of Asia Pacific
  • 14.13. Market Attractiveness Analysis
    • 14.13.1. By Product Type
    • 14.13.2. By Technology
    • 14.13.3. By Disease Type
    • 14.13.4. By Animal Type
    • 14.13.5. By End-user
    • 14.13.6. By Country/Sub-region

15. Latin America Veterinary Molecular Diagnostics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2017-2031
    • 15.2.1. Instruments & Software
    • 15.2.2. Kits & Reagents
    • 15.2.3. Services
  • 15.3. Market Attractiveness, by Product Type
  • 15.4. Market Value Forecast, by Technology, 2017-2031
    • 15.4.1. Conventional PCR
    • 15.4.2. Singleplex PCR
    • 15.4.3. Multiplex PCR
    • 15.4.4. Real-time PCR
    • 15.4.5. Others
  • 15.5. Market Attractiveness, by Technology
  • 15.6. Market Value Forecast, By Disease Type, 2017-2031
    • 15.6.1. Vector-borne Diseases
    • 15.6.2. Respiratory Pathogens
    • 15.6.3. Diarrhea Pathogens
    • 15.6.4. Others
  • 15.7. Market Attractiveness, By Disease Type
  • 15.8. Market Value Forecast, by Animal Type, 2017-2031
    • 15.8.1. Companion Animal
    • 15.8.2. Livestock Animal
  • 15.9. Market Attractiveness, by Animal Type
  • 15.10. Market Value Forecast, by User End-user, 2017-2031
    • 15.10.1. Hospitals/Clinics
    • 15.10.2. Reference Laboratories
  • 15.11. Market Attractiveness, by End-user
  • 15.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.12.1. Brazil
    • 15.12.2. Mexico
    • 15.12.3. Rest of Latin America
  • 15.13. Market Attractiveness Analysis
    • 15.13.1. By Product Type
    • 15.13.2. By Technology
    • 15.13.3. By Disease Type
    • 15.13.4. By Animal Type
    • 15.13.5. By End-user
    • 15.13.6. By Country/Sub-region

16. Middle East & Africa Veterinary Molecular Diagnostics Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Product Type, 2017-2031
    • 16.2.1. Instruments & Software
    • 16.2.2. Kits & Reagents
    • 16.2.3. Services
  • 16.3. Market Attractiveness, by Product Type
  • 16.4. Market Value Forecast, by Technology, 2017-2031
    • 16.4.1. Conventional PCR
    • 16.4.2. Singleplex PCR
    • 16.4.3. Multiplex PCR
    • 16.4.4. Real-time PCR
    • 16.4.5. Others
  • 16.5. Market Attractiveness, by Technology
  • 16.6. Market Value Forecast, By Disease Type, 2017-2031
    • 16.6.1. Vector-borne Diseases
    • 16.6.2. Respiratory Pathogens
    • 16.6.3. Diarrhea Pathogens
    • 16.6.4. Others
  • 16.7. Market Attractiveness, By Disease Type
  • 16.8. Market Value Forecast, by Animal Type, 2017-2031
    • 16.8.1. Companion Animal
    • 16.8.2. Livestock Animal
  • 16.9. Market Attractiveness, by Animal Type
  • 16.10. Market Value Forecast, by User End-user, 2017-2031
    • 16.10.1. Hospitals/Clinics
    • 16.10.2. Reference Laboratories
  • 16.11. Market Attractiveness, by End-user
  • 16.12. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.12.1. GCC Countries
    • 16.12.2. South Africa
    • 16.12.3. Rest of Middle East & Africa
  • 16.13. Market Attractiveness Analysis
    • 16.13.1. By Product Type
    • 16.13.2. By Technology
    • 16.13.3. By Disease Type
    • 16.13.4. By Animal Type
    • 16.13.5. By End-user
    • 16.13.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 17.2. Market Share Analysis, by Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. IDEXX Laboratories, Inc.
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. Thermo Fisher Scientific, Inc.
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. Zoetis, Inc.
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. Neogen Corporation
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. bioMerieux SA
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. QIAGEN N.V.
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. Biomedica Medizinprodukte GmbH
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview
    • 17.3.8. Bioneer
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. SWOT Analysis
      • 17.3.8.5. Strategic Overview
    • 17.3.9. Mars, Incorporated
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. SWOT Analysis
      • 17.3.9.5. Strategic Overview
    • 17.3.10. Innovative Diagnostics
      • 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.10.2. Product Portfolio
      • 17.3.10.3. Financial Overview
      • 17.3.10.4. SWOT Analysis
      • 17.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 03: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 04: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017-2031
  • Table 05: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 09: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 10: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017-2031
  • Table 11: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 12: North America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 15: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 16: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017-2031
  • Table 17: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 18: Europe Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 19: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 21: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 22: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017-2031
  • Table 23: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 24: Asia Pacific Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 27: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 28: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017-2031
  • Table 29: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 30: Latin America Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 33: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 34: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, By Disease Type, 2017-2031
  • Table 35: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by Animal Type, 2017-2031
  • Table 36: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Veterinary Molecular Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Product Type, 2022
  • Figure 03: Global Veterinary Molecular Diagnostics Market Value Share, by Product Type, 2022
  • Figure 04: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Technology, 2022
  • Figure 05: Global Veterinary Molecular Diagnostics Market Value Share, by Technology, 2022
  • Figure 06: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), By Disease Type, 2022
  • Figure 07: Global Veterinary Molecular Diagnostics Market Value Share, By Disease Type, 2022
  • Figure 08: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Animal Type, 2022
  • Figure 09: Global Veterinary Molecular Diagnostics Market Value Share, by Animal Type, 2022
  • Figure 10: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 11: Global Veterinary Molecular Diagnostics Market Value Share, by End-user, 2022
  • Figure 12: Global Veterinary Molecular Diagnostics Market Value Share, by Region, 2022
  • Figure 13: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 14: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 15: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 16: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022-2031
  • Figure 17: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 18: Global Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022-2031
  • Figure 19: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031
  • Figure 20: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by Animal Type, 2022
  • Figure 21: Global Veterinary Molecular Diagnostics Market Value Share, by Animal Type, 2022
  • Figure 22: Global Veterinary Molecular Diagnostics Market Revenue (US$ Mn), by End-user, 2022
  • Figure 23: Global Veterinary Molecular Diagnostics Market Value Share, by End-user, 2022
  • Figure 24: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Region, 2022-2031
  • Figure 25: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 26: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 27: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Country, 2022-2031
  • Figure 29: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 30: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022-2031
  • Figure 31: North America Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022-2031
  • Figure 32: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022-2031
  • Figure 33: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022-2031
  • Figure 34: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 35: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 36: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031
  • Figure 37: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 38: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 39: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 40: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 41: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 42: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 43: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022-2031
  • Figure 44: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022-2031
  • Figure 45: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022-2031
  • Figure 46: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022-2031
  • Figure 47: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 48: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 49: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031
  • Figure 50: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 51: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 52: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 53: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 54: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 55: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 56: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022-2031
  • Figure 57: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022-2031
  • Figure 58: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022-2031
  • Figure 59: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022-2031
  • Figure 60: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 61: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 62: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031
  • Figure 63: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 64: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 65: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 66: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 67: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 68: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 69: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022-2031
  • Figure 70: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022-2031
  • Figure 71: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022-2031
  • Figure 72: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022-2031
  • Figure 73: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 74: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 75: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031
  • Figure 76: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 77: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 78: Middle East & Africa Veterinary Molecular Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 79: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 80: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 81: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2022-2031
  • Figure 82: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2022-2031
  • Figure 83: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, By Disease Type, 2022-2031
  • Figure 84: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2022-2031
  • Figure 85: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by User End-user, 2022-2031
  • Figure 86: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 87: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 88: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, By Disease Type, 2023-2031
  • Figure 89: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2023-2031
  • Figure 90: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031